|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
He SB, Yuan Y, Wang L, Yu MJ, Zhu YB and
Zhu XG: Effects of cyclin-dependent kinase 8 specific siRNA on the
proliferation and apoptosis of colon cancer cells. J Exp Clin
Cancer Res. 30:1092011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wan D, He S, Xie B, Xu G, Gu W, Shen C, Hu
Y, Wang X, Zhi Q and Wang L: Aberrant expression of miR-199a-3p and
its clinical significance in colorectal cancers. Med Oncol.
30:3782013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Markowitz SD and Bertagnolli MM: Molecular
origins of cancer: molecular basis of colorectal cancer. N Engl J
Med. 361:2449–2460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Walther A, Johnstone E, Swanton C, Midgley
R, Tomlinson I and Kerr D: Genetic prognostic and predictive
markers in colorectal cancer. Nat Rev Cancer. 9:489–499. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen HJ, Hsu LS, Shia YT, Lin MW and Lin
CM: The β-catenin/TCF complex as a novel target of resveratrol in
the Wnt/β-catenin signaling pathway. Biochem Pharmacol.
84:1143–1153. 2012.
|
|
8
|
Firestein R and Hahn WC: Revving the
Throttle on an oncogene: CDK8 takes the driver seat. Cancer Res.
69:7899–7901. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luu HH, Zhang R, Haydon RC, Rayburn E,
Kang Q, Si W, Park JK, Wang H, Peng Y, Jiang W and He TC:
Wnt/β-catenin signaling pathway as a novel cancer drug target. Curr
Cancer Drug Targets. 4:653–671. 2004.
|
|
10
|
Dihlmann S and von Knebel Doeberitz M:
Wnt/β-catenin-pathway as a molecular target for future anti-cancer
therapeutics. Int J Cancer. 113:515–524. 2005.
|
|
11
|
Kundu JK, Choi KY and Surh YJ:
β-catenin-mediated signaling: a novel molecular target for
chemoprevention with anti-inflammatory substances. Biochim Biophys
Acta. 1765:14–24. 2006.
|
|
12
|
Kim SA, Lee Y, Jung DE, Park KH, Park JY,
Gang J, Jeon SB, Park EC, Kim YG, Lee B, Liu Q, Zeng W, Yeramilli
S, Lee S, Koh SS and Song SY: Pancreatic adenocarcinoma
up-regulated factor (PAUF), a novel up-regulated secretory protein
in pancreatic ductal adenocarcinoma. Cancer Sci. 100:828–836. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cho IR, Koh SS, Min HJ, Kim SJ, Lee Y,
Park EH, Ratakorn S, Jhun BH, Oh S, Johnston RN and Chung YH:
Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the
expression of β-catenin, leading to a rapid proliferation of
pancreatic cells. Exp Mol Med. 43:82–90. 2011.PubMed/NCBI
|
|
14
|
Bienz M and Clevers H: Linking colorectal
cancer to Wnt signaling. Cell. 103:311–320. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nelson WJ and Nusse R: Convergence of Wnt,
β-catenin, and cadherin pathways. Science. 303:1483–1487. 2004.
|
|
16
|
Coluccia AM, Benati D, Dekhil H, De
Filippo A, Lan C and Gambacorti-Passerini C: SKI-606 decreases
growth and motility of colorectal cancer cells by preventing
pp60(c-Src)-dependent tyrosine phosphorylation of β-catenin and its
nuclear signaling. Cancer Res. 66:2279–2286. 2006.PubMed/NCBI
|
|
17
|
Seo JO, Han SI and Lim SC: Role of CDK8
and β-catenin in colorectal adenocarcinoma. Oncol Rep. 24:285–291.
2010.
|
|
18
|
Firestein R, Bass AJ, Kim SY, Dunn IF,
Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S, Chheda MG,
Tamayo P, Finn S, Shrestha Y, Boehm JS, Jain S, Bojarski E, Mermel
C, Barretina J, Chan JA, Baselga J, Tabernero J, Root DE, Fuchs CS,
Loda M, Shivdasani RA, Meyerson M and Hahn WC: CDK8 is a colorectal
cancer oncogene that regulates β-catenin activity. Nature.
455:547–551. 2008.PubMed/NCBI
|
|
19
|
Morris EJ, Ji JY, Yang F, Di Stefano L,
Herr A, Moon NS, Kwon EJ, Haigis KM, Näär AM and Dyson NJ: E2F1
represses β-catenin transcription and is antagonized by both pRB
and CDK8. Nature. 455:552–556. 2008.
|
|
20
|
Lee Y, Kim SJ, Park HD, Park EH, Huang SM,
Jeon SB, Kim JM, Lim DS and Koh SS: PAUF functions in the
metastasis of human pancreatic cancer cells and upregulates CXCR4
expression. Oncogene. 29:56–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park HD, Lee Y, Oh YK, Jung JG, Park YW,
Myung K, Kim KH, Koh SS and Lim DS: Pancreatic adenocarcinoma
upregulated factor promotes metastasis by regulating TLR/CXCR4
activation. Oncogene. 30:201–211. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee YS, Kim SJ, Min HJ, Jo JY, Park EH and
Koh SS: PAUF promotes adhesiveness of pancreatic cancer cells by
modulating focal adhesion kinase. Exp Mol Med. 43:291–297. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim YH, Sung HJ, Kim S, Kim EO, Lee JW,
Moon JY, Choi K, Jung JE, Lee Y, Koh SS, Rhee SG, Heo K and Kim IH:
An RNA aptamer that specifically binds pancreatic adenocarcinoma
up-regulated factor inhibits migration and growth of pancreatic
cancer cells. Cancer Lett. 313:76–83. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Merritt WM, Bar-Eli M and Sood AK: The
dicey role of dicer: implications for RNAi therapy. Cancer Res.
70:2571–2574. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brummelkamp TR, Bemards R and Agami R:
Stable suppression of tumorigenicity by virus-mediated RNA
interference. Cancer Cell. 2:243–247. 2002. View Article : Google Scholar : PubMed/NCBI
|
